TYLER, Texas--(BUSINESS WIRE)-- NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, announced today, through its ...
Patent strengthens ENvue’s IP position as it advances toward pediatric regulatory clearance and expanded clinical use This newly granted patent covers ENvue’s proprietary system and is designed to ...
NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic devices, announced today that a regional acute care hospital ...
ELMSFORD, N.Y. - NanoVibronix , Inc. (NASDAQ:NAOV), a medical device company with a current market capitalization of $2.25 million, has announced the acquisition of ENvue Medical (TASE:PMCN) Holdings ...
Considering lung collapse (pneumothorax) affects 2-5% of 35 million feeding tube placements every year worldwide, the safe placement of a nasogastric feeding tube requires special medical care.
After seven years of bad luck for Avanos Medical’s enteral feeding tube placement system, the FDA has handed down its most serious designation for a recall of the device. The Cortrak*2 Enteral Access ...
The US Food and Drug Administration (FDA) has received numerous reports of pneumothorax events associated with feeding tube placement procedures performed by using two of the three FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback